查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945370

2026年全球感染疾病診斷檢測市場報告

Infectious Disease Diagnostics Testing Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，感染疾病診斷檢測市場發展迅速，預計將以10.0%的複合年成長率成長，從2025年的422.4億美元成長到2026年的464.8億美元。過去幾年的成長歸因於多種因素，例如感染疾病病率的上升、呼吸道感染疾病發病率的增加、診斷檢測設施的擴建、人們對早期診斷意識提升以及各國政府對疾病預防的日益重視。

預計未來幾年，感染疾病診斷檢測市場將維持強勁成長，到2030年市場規模將達到654.9億美元，複合年成長率（CAGR）為9.0%。預測期內的成長要素包括：全球疫情風險不斷上升、對快速診斷解決方案的需求日益成長、醫療診斷投資不斷增加、疾病監測項目不斷擴大以及熱帶疾病和病毒性疾病負擔日益加重。預測期內的主要趨勢包括：對感染疾病快速早期檢測的需求不斷成長、照護現場）傳染病檢查的普及率不斷提高、分子診斷在病原體鑑定中的應用日益廣泛、針對新發和再發感染疾病的診斷檢測不斷擴大，以及對大規模疾病篩檢和監測的日益重視。

由於呼吸道感染疾病的增加，感染疾病診斷檢測市場預計將會成長。呼吸道感染疾病會影響呼吸系統的各個部位，其原因是病毒和細菌透過密切接觸、不衛生的環境、擁擠的居住環境以及季節性變化等因素傳播。感染疾病診斷檢測對於準確識別和治療呼吸道感染疾病至關重要，能夠精確檢測患者檢體中的病毒和細菌等病原體。例如，根據加拿大健康資訊研究所的報告，2023年因急性上呼吸道感染疾病住院的人數增加了32%，從2022年的2114人增加到2797人。

感染疾病診斷檢測市場的主要企業正在開發創新技術，以快速、準確地檢測關鍵感染疾病。感染疾病診斷能夠識別病原體，例如細菌、病毒和寄生蟲，從而指南診斷和治療。例如，2025年1月，總部位於德國的生物技術公司凱傑（QIAGEN）在印度推出了其新型QIAstat-Dx症候群檢測組合。該組合包括胃腸道疾病組合2和腦膜炎/腦炎組合，以及先前已獲批准的呼吸道SARS-CoV-2組合，這兩個組合均已獲得印度中央藥品標準控制組織（CDSCO）的核准。 QIAstat-Dx系統採用多重即時PCR技術及一次性試劑盒，可同時檢測多種病原體。胃腸道感染疾病的檢測結果大約需要1小時，中樞神經系統感染疾病的檢測結果約80分鐘。與傳統方法相比，這些檢測組合提高了診斷速度和準確性，從而能夠及時治療，改善患者預後，並減輕醫療系統的負擔。該系統還具有可設定配置和雲端連接功能，可實現遠端監控和高效的資料管理。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球感染疾病診斷檢測市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 人工智慧（AI）和自主人工智慧
    • 數位化、雲端運算、巨量資料、網路安全
    • 物聯網、智慧基礎設施和互聯生態系統
    • 工業4.0和智慧製造
  • 主要趨勢
    • 感染疾病快速及早期檢測的需求日益成長
    • 擴大照護現場傳染病檢查的應用
    • 擴大分子診斷技術在病原體鑑定上的應用
    • 擴大新發和再發感染疾病的診斷檢測
    • 更重視大規模疾病篩檢和監測

第5章 終端用戶產業市場分析

  • 診斷檢查室
  • 醫院和診所
  • 學術研究機構
  • 公共衛生研究所
  • 標準與檢驗組織

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球感染疾病診斷檢測市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球感染疾病診斷檢測市場規模、對比及成長率分析
  • 全球感染疾病診斷檢測市場表現：規模與成長，2020-2025年
  • 全球感染疾病診斷檢測市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 按類型
  • 分子診斷檢測、就地檢驗（POC​​T）感染疾病檢測
  • 透過使用
  • 呼吸道疾病、人類免疫力缺乏病毒（HIV）感染、醫療相關感染疾病（HAI）、性行為感染、熱帶疾病
  • 最終用戶
  • 診斷檢查室、醫院和診所
  • 按類型細分：分子診斷測試
  • 聚合酵素鏈鎖反應（PCR）檢測、核酸增幅檢查（NAAT）
  • 按類型細分：就地檢驗（POC​​T）感染疾病診斷測試
  • 橫向流動化驗、快速抗原檢測、免疫檢測、可攜式PCR

第10章 區域與國家分析

  • 全球感染疾病診斷檢測市場：區域表現及預測，2020-2025年、2025-2030年預測、2035年預測
  • 全球感染疾病診斷檢測市場：依國家/地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 感染疾病診斷檢測市場：競爭格局及市場佔有率（2024年）
  • 感染疾病診斷檢測市場：公司估值矩陣
  • 感染疾病診斷檢測市場：公司概況
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Danaher Corporation
    • Siemens Healthineers AG

第37章：其他領先和創新企業

  • Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols SA, Hologic Inc., PerkinElmer Inc., bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, DiaSorin SpA（Luminex）, Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年感染疾病診斷檢測市場：提供新機會的國家
  • 2030年感染疾病診斷檢測市場：充滿新機會的細分市場
  • 2030年感染疾病診斷檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME3MIDDT01_G26Q1

Infectious disease diagnostics testing involves identifying the presence of pathogens, such as bacteria, viruses, fungi, or parasites, in a patient's body. These tests are critical for diagnosing infectious diseases and making appropriate treatment decisions. They play a crucial role in controlling the spread of infectious diseases, guiding treatment choices, and monitoring outbreaks.

The main types of infectious disease diagnostics testing are molecular diagnostic tests and point-of-care tests (POCT) for infectious diseases. Molecular diagnostic testing refers to laboratory techniques that detect and analyze genetic material (DNA or RNA) to diagnose diseases, identify pathogens, and predict treatment responses. These tests find applications in areas such as respiratory infections, human immunodeficiency virus (HIV), healthcare-associated infections (HAIS), sexual health, tropical diseases, and liver diseases. They are utilized by various end-users including diagnostic laboratories, hospitals and clinics, academic research institutes, and other healthcare providers.

Tariffs have created supply chain challenges and cost pressures in the infectious disease diagnostics testing market by increasing duties on reagents, diagnostic kits, laboratory instruments, and electronic components. These impacts have raised production and procurement costs, particularly affecting molecular diagnostics and point of care test segments, with north america and asia-pacific regions experiencing greater exposure due to reliance on imported consumables. Diagnostic laboratories and hospitals have faced pricing pressures and procurement delays. On the positive side, tariffs have encouraged local manufacturing, regional sourcing of test kits, and strengthened domestic diagnostic supply capabilities, supporting long-term market resilience.

The infectious disease diagnostics testing market research report is one of a series of new reports from The Business Research Company that provides infectious disease diagnostics testing market statistics, including infectious disease diagnostics testing industry global market size, regional shares, competitors with a infectious disease diagnostics testing market share, detailed infectious disease diagnostics testing market segments, market trends and opportunities, and any further data you may need to thrive in the infectious disease diagnostics testing industry. This infectious disease diagnostics testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The infectious disease diagnostics testing market size has grown rapidly in recent years. It will grow from $42.24 billion in 2025 to $46.48 billion in 2026 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to increasing prevalence of infectious diseases, rising incidence of respiratory infections, expansion of diagnostic laboratory infrastructure, growing awareness of early disease diagnosis, increased government focus on disease control.

The infectious disease diagnostics testing market size is expected to see strong growth in the next few years. It will grow to $65.49 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to rising risk of global pandemics, increasing demand for rapid diagnostic solutions, growing investments in healthcare diagnostics, expanding disease surveillance programs, rising burden of tropical and viral diseases. Major trends in the forecast period include rising demand for rapid and early infectious disease detection, growing adoption of point of care infectious disease tests, increasing use of molecular diagnostics for pathogen identification, expansion of diagnostic testing for emerging and re-emerging infections, growing focus on large-scale disease screening and surveillance.

The infectious disease diagnostic testing market is anticipated to experience growth due to an increase in respiratory infections. Respiratory infections affect various parts of the respiratory system and are caused by viral and bacterial transmission through close contact, poor hygiene, crowded living conditions, and seasonal variations. Diagnostic testing for infectious diseases is crucial for accurate identification and treatment of respiratory infections, enabling the precise detection of pathogens such as viruses and bacteria in patient samples. For example, hospitalizations for acute upper respiratory infections saw a 32% increase from 2,114 cases in 2022 to 2,797 cases in 2023, as reported by the Canadian Institute for Health Information.

Major companies in the infectious disease diagnostic testing market are developing innovative technologies to rapidly and accurately detect critical infections. Infectious disease diagnostics involves identifying pathogens, such as bacteria, viruses, or parasites, to guide diagnosis and treatment. For example, in January 2025, QIAGEN, a Germany-based biotechnology company, launched new QIAstat-Dx syndromic testing panels in India, including the Gastrointestinal Panel 2 and Meningitis/Encephalitis Panel, alongside the previously authorized Respiratory SARS-CoV-2 Panel, all approved by India's Central Drugs Standard Control Organization (CDSCO). The QIAstat-Dx system uses multiplex real-time PCR with single-use cartridges to detect multiple pathogens simultaneously, providing results in about an hour for gastrointestinal infections and 80 minutes for central nervous system infections. These panels improve diagnostic speed and accuracy compared to traditional methods, enabling timely treatment, enhancing patient outcomes, and reducing healthcare system burdens. The system also offers configurable setups and cloud connectivity for remote monitoring and efficient data management.

In July 2024, Roche, a Switzerland-based company, acquired the point-of-care technology business of LumiraDx for an undisclosed amount. Through this acquisition, Roche aimed to accelerate its growth in decentralized and primary-care testing by integrating LumiraDx's multi-assay platform, which can perform immunoassay, clinical chemistry, and, with future development, molecular diagnostics. LumiraDx is a UK-based provider of infectious disease diagnostic testing.

Major companies operating in the infectious disease diagnostics testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin SpA (Luminex), Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc., Trinity Biotech PLC

North America was the largest region in the infectious disease diagnostics testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the infectious disease diagnostics testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The infectious disease diagnostics testing market consists of revenues earned by entities by providing services such as laboratory testing, point-of-care testing, molecular diagnostics, immunoassays, and rapid diagnostic tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The infectious disease diagnostics testing market also includes sales of diagnostic kits, reagents, instruments, and software used for detecting and identifying infectious agents in patients. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Infectious Disease Diagnostics Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses infectious disease diagnostics testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for infectious disease diagnostics testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The infectious disease diagnostics testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Molecular Diagnostic Test; Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
  • 2) By Application: Respiratory; Human Immunodeficiency Virus (HIV); Healthcare-Associated Infections (HAIs); Sexual Health; Tropical Diseases
  • 3) By End-User: Diagnostic Laboratories; Hospitals And Clinics
  • Subsegments:
  • 1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests; Nucleic Acid Amplification Tests (NAATs)
  • 2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays; Rapid Antigen Tests; Immunoassays; Portable PCR
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Becton Dickinson And Company; Quest Diagnostics Incorporated; Grifols S.A.; Hologic Inc.; PerkinElmer Inc.; bioMerieux SA; Quidel Corporation; Sysmex Corporation; Bio-Rad Laboratories Inc.; QIAGEN N.V.; DiaSorin SpA (Luminex); Seegene Inc.; Ortho Clinical Diagnostics Inc.; OraSure Technologies Inc.; Meridian Bioscience Inc.; Trinity Biotech PLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Infectious Disease Diagnostics Testing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Infectious Disease Diagnostics Testing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Infectious Disease Diagnostics Testing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Infectious Disease Diagnostics Testing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Rising Demand For Rapid And Early Infectious Disease Detection
    • 4.2.2 Growing Adoption Of Point Of Care Infectious Disease Tests
    • 4.2.3 Increasing Use Of Molecular Diagnostics For Pathogen Identification
    • 4.2.4 Expansion Of Diagnostic Testing For Emerging And Re-Emerging Infections
    • 4.2.5 Growing Focus On Large-Scale Disease Screening And Surveillance

5. Infectious Disease Diagnostics Testing Market Analysis Of End Use Industries

  • 5.1 Diagnostic Laboratories
  • 5.2 Hospitals And Clinics
  • 5.3 Academic Research Institutes
  • 5.4 Public Health Laboratories
  • 5.5 Reference Laboratories

6. Infectious Disease Diagnostics Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Infectious Disease Diagnostics Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Infectious Disease Diagnostics Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Infectious Disease Diagnostics Testing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Infectious Disease Diagnostics Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Infectious Disease Diagnostics Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Infectious Disease Diagnostics Testing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Infectious Disease Diagnostics Testing Market Segmentation

  • 9.1. Global Infectious Disease Diagnostics Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
  • 9.2. Global Infectious Disease Diagnostics Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Respiratory, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Sexual Health, Tropical Diseases
  • 9.3. Global Infectious Disease Diagnostics Testing Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diagnostic Laboratories, Hospitals And Clinics
  • 9.4. Global Infectious Disease Diagnostics Testing Market, Sub-Segmentation Of Molecular Diagnostic Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction (PCR) Tests, Nucleic Acid Amplification Tests (NAATs)
  • 9.5. Global Infectious Disease Diagnostics Testing Market, Sub-Segmentation Of Point Of Care Tests (POCT) Infectious Disease Diagnostics Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Lateral Flow Assays, Rapid Antigen Tests, Immunoassays, Portable PCR

10. Infectious Disease Diagnostics Testing Market Regional And Country Analysis

  • 10.1. Global Infectious Disease Diagnostics Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Infectious Disease Diagnostics Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Infectious Disease Diagnostics Testing Market

  • 11.1. Asia-Pacific Infectious Disease Diagnostics Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Infectious Disease Diagnostics Testing Market

  • 12.1. China Infectious Disease Diagnostics Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Infectious Disease Diagnostics Testing Market

  • 13.1. India Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Infectious Disease Diagnostics Testing Market

  • 14.1. Japan Infectious Disease Diagnostics Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Infectious Disease Diagnostics Testing Market

  • 15.1. Australia Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Infectious Disease Diagnostics Testing Market

  • 16.1. Indonesia Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Infectious Disease Diagnostics Testing Market

  • 17.1. South Korea Infectious Disease Diagnostics Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Infectious Disease Diagnostics Testing Market

  • 18.1. Taiwan Infectious Disease Diagnostics Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Infectious Disease Diagnostics Testing Market

  • 19.1. South East Asia Infectious Disease Diagnostics Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Infectious Disease Diagnostics Testing Market

  • 20.1. Western Europe Infectious Disease Diagnostics Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Infectious Disease Diagnostics Testing Market

  • 21.1. UK Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Infectious Disease Diagnostics Testing Market

  • 22.1. Germany Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Infectious Disease Diagnostics Testing Market

  • 23.1. France Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Infectious Disease Diagnostics Testing Market

  • 24.1. Italy Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Infectious Disease Diagnostics Testing Market

  • 25.1. Spain Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Infectious Disease Diagnostics Testing Market

  • 26.1. Eastern Europe Infectious Disease Diagnostics Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Infectious Disease Diagnostics Testing Market

  • 27.1. Russia Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Infectious Disease Diagnostics Testing Market

  • 28.1. North America Infectious Disease Diagnostics Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Infectious Disease Diagnostics Testing Market

  • 29.1. USA Infectious Disease Diagnostics Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Infectious Disease Diagnostics Testing Market

  • 30.1. Canada Infectious Disease Diagnostics Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Infectious Disease Diagnostics Testing Market

  • 31.1. South America Infectious Disease Diagnostics Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Infectious Disease Diagnostics Testing Market

  • 32.1. Brazil Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Infectious Disease Diagnostics Testing Market

  • 33.1. Middle East Infectious Disease Diagnostics Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Infectious Disease Diagnostics Testing Market

  • 34.1. Africa Infectious Disease Diagnostics Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Infectious Disease Diagnostics Testing Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Infectious Disease Diagnostics Testing Market Regulatory and Investment Landscape

36. Infectious Disease Diagnostics Testing Market Competitive Landscape And Company Profiles

  • 36.1. Infectious Disease Diagnostics Testing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Infectious Disease Diagnostics Testing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Infectious Disease Diagnostics Testing Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

37. Infectious Disease Diagnostics Testing Market Other Major And Innovative Companies

  • Becton Dickinson And Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMerieux SA, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin SpA (Luminex), Seegene Inc., Ortho Clinical Diagnostics Inc., OraSure Technologies Inc., Meridian Bioscience Inc.

38. Global Infectious Disease Diagnostics Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Infectious Disease Diagnostics Testing Market

40. Infectious Disease Diagnostics Testing Market High Potential Countries, Segments and Strategies

  • 40.1 Infectious Disease Diagnostics Testing Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Infectious Disease Diagnostics Testing Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Infectious Disease Diagnostics Testing Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer